Osteoarthritis drug withdrawn from the UK market following hepatotoxicity fears

摘要

Human trials begin for rheumatoid arthritis drugnnnnnnReport concludes that science at the US FDA is highly inadequatennnnnnExercise program may help alleviate arthritisnnnnnnGrowth hormone as a potential fibromyalgia treatmentnnnnnnControversy over bisphosphonates continues